Nf Kb

NF-kB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is a critical protein complex that plays a central role in regulating gene expression, particularly in immune responses and cellular stress.

Nf Kb

Key Takeaways

  • NF-kB is a ubiquitous transcription factor found in nearly all animal cell types.
  • It is crucial for regulating genes involved in immune responses, inflammation, cell survival, and proliferation.
  • The activation of NF-kB typically involves a signaling pathway that leads to its translocation from the cytoplasm to the nucleus.
  • Dysregulation of NF-kB activity is implicated in various diseases, including chronic inflammatory disorders and cancer.

What is NF-kB (Nuclear Factor kappa-light-chain-enhancer of activated B cells)?

NF-kB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) refers to a protein complex that functions as a transcription factor, meaning it controls the transcription of DNA into RNA. Found in almost all animal cell types, NF-kB plays a pivotal role in cellular responses to stimuli such as stress, cytokines, free radicals, heavy metals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. In its inactive state, NF-kB is typically sequestered in the cytoplasm, bound to inhibitory proteins known as IκBs (Inhibitor of kappa B).

Upon activation, NF-kB translocates to the nucleus, where it binds to specific DNA sequences and regulates the expression of a vast array of genes. These genes are involved in critical cellular processes, including immune and inflammatory responses, cell growth, proliferation, and survival. The precise control over NF-kB activity is essential for maintaining cellular homeostasis and preventing disease.

The NF-kB Signaling Pathway Explained

The NF-kB pathway explanation primarily revolves around its activation, which is triggered by various extracellular and intracellular signals. The most well-understood mechanism is the canonical NF-kB pathway. This pathway begins when specific receptors on the cell surface, such as Toll-like receptors (TLRs) or TNF receptors, detect activating stimuli.

Upon receptor activation, a cascade of intracellular signaling events leads to the activation of the IκB kinase (IKK) complex. The IKK complex then phosphorylates the IκB proteins, marking them for ubiquitination and subsequent degradation by the proteasome. The degradation of IκB releases NF-kB, which is now free to translocate into the cell nucleus. Once in the nucleus, NF-kB binds to specific DNA promoter regions of target genes, initiating their transcription and leading to the production of various proteins that mediate cellular responses.

Key steps in the canonical NF-kB activation pathway include:

  • Stimulus binding to cell surface receptors.
  • Activation of the IKK complex.
  • Phosphorylation and degradation of IκB proteins.
  • Translocation of NF-kB into the nucleus.
  • Binding to DNA and gene transcription.

NF-kB’s Role in Cellular Function and Inflammation

The NF-kB function in cells is remarkably diverse, influencing a wide range of physiological and pathological processes. It is a master regulator of the immune system, orchestrating both innate and adaptive immune responses. For instance, NF-kB promotes the production of cytokines, chemokines, and adhesion molecules that are vital for recruiting immune cells to sites of infection or injury. Beyond immunity, NF-kB also plays roles in cell proliferation, differentiation, and survival, often acting as an anti-apoptotic factor that helps cells resist programmed cell death.

The central role of NF-kB in inflammation is particularly significant. By inducing the expression of numerous pro-inflammatory genes, NF-kB acts as a crucial mediator in the initiation and perpetuation of inflammatory responses. While acute inflammation is a vital protective mechanism against pathogens and tissue damage, chronic or uncontrolled activation of NF-kB can contribute to various inflammatory diseases, including autoimmune disorders, atherosclerosis, and certain types of cancer. Understanding and modulating NF-kB activity is therefore a key area of research for developing new therapeutic strategies for these conditions.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.